DGICB Q1 2026 Earnings EPS Misses Estimates Amidst Challenging Underwriting Environment ADI Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges REG Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience MGY Q1 2026 Earnings Modest EPS Beat as Operational Discipline Continues Nordson NDSN Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower